GFP
BIVV

Gryphon Financial Partners’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Gryphon Financial Partners’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-87
Closed -$4K – 1060
2017
Q4 		$4K Buy
+87
New +$4.76K ﹤0.01% 826

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Gryphon Financial Partners's BIVV Position: Q1 2018 in Review

Gryphon Financial Partners sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 87 shares — an estimated $4K sold.

Gryphon Financial Partners first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Gryphon Financial Partners reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Gryphon Financial Partners sold 87 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $4K.
  • Gryphon Financial Partners first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
  • Gryphon Financial Partners's Bioverativ Inc. Common Stock position peaked at $4K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Gryphon Financial Partners's 13F filing for Q1 2018, filed 14 May 2018.